{
    "links": "https://www.ycombinator.com/companies/helix-nanotechnologies",
    "name": "Helix Nanotechnologies",
    "headline": "Next-generation mRNA platform to solve cancer, COVID and climate.",
    "batch": "W17",
    "description": "Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button.\r\n\nBy focusing on mRNA improvements from first principles, we\u2019re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity.\r\n\nRigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we\u2019ll find the really cool ideas.\r\n\nWe've started rolling out some of our new tech \u2014 moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we\u2019re scientists at heart, and team focus is solidly on the horizon.",
    "activity_status": "Active",
    "website": "http://helixnano.com",
    "founded_date": null,
    "team_size": 16.0,
    "location": "Boston",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:artificial-intelligence; industry:biotech; industry:genomics; industry:nanotechnology; location:boston",
    "founders": [],
    "status": true,
    "generated_description": "**Helix Nanotechnologies: Redefining mRNA Solutions for Global Challenges**\n\nFounded in the Y Combinator Batch W17 and located in Boston, Helix Nanotechnologies is carving out its niche at the intersection of biotechnology, genomics, and nanotechnology. With a dedicated team of 16 visionaries, their mission is straightforward yet profound: to create a next-generation mRNA platform aimed at tackling cancer, COVID-19, and climate change.\n\nAt Helix Nano, the approach is refreshingly innovative. They recognize that just like technology finds and delivers information quickly, mRNA can revolutionize biological responses. The vision here is to democratize health solutions, making treatments affordable and customizable\u2014essentially allowing you to modify biology at the push of a button.\n\nWhy are they getting there faster than expected? They're honing in on mRNA advancements through first principles, which has slashed the time for experiments from months or years to mere weeks, cutting costs significantly from millions to thousands. The only constraint they face now? Scientific curiosity.\n\nThe culture at Helix Nano is equally compelling. They reject rigid hierarchies; the company thrives on the nimble ideas sprouting from all team members, including those at junior levels. A diverse team isn't just a checkbox for them; it's a catalyst for innovation, speeding up the discovery of groundbreaking ideas.\n\nCurrently, some of their projects in the pipeline include moving a COVID-19 vaccine candidate tailored for the immunocompromised toward clinical trials, and exploring interventions that could have a massive positive impact on the environment.\n\nHelix Nanotechnologies is not just about science; it's about a vision for a better, healthier world where barriers are lowered, and scientific breakthroughs are more accessible. If you're as fascinated by the possibilities at the frontier of biotechnology as they are, you just might want to keep an eye on their progress.\n\nFor more information, check out their website: [helixnano.com](http://helixnano.com).",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/0c66f27550ac39a8a8ccbf748f15608b1aa325fd.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAJMV6TLGB%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191416Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJGMEQCIFLa1ybFb1MW3YWarl6N2DZLtQ4R6h64JtRzg2nxAowaAiB3nTk9Wj2wgaQBuQdmXKSYUK01s%2FfzNcIsI%2FpnnVYrDCruAwjc%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F8BEAAaDDAwNjIwMTgxMTA3MiIMbK4eHGyZbeOmKiEOKsIDEgeFqYzoIm9WYPES%2BanLfTcQEGyzIks%2Fal2Lmqxe4p56ewXYsETQE6xKLCXrmvzZNyUDpx5dtkyRoWAO6FYyXXGaPQzEZ3lyFdj%2BxmzYPjn73zyfO0POWT06n60Ss4FWi%2BsXTCqzCDlztmj5P3pe%2BccFf3AJ6Fob0iUEcgWZg86XqS2niw4lXPnalb%2Boq3NuXvHl2oVLzjcW3kqbNIZD4bJeuP%2BaiX3YtJ%2BJXjqRV4JMYzbegC89ld8%2FQ6Niu9GP6iWyA3Ij%2Frc6v9eF94GLnVFmDUIq%2FgOldm3US8WLOYW64cbfEYgRv4%2BZqFOZik7gMqvr0%2BAMO66zctStkeS7pQEndome2HMXzolZnAHIKHa7syJwRucmMBn1qLVqGHDFwDTWD66ZqASdClXaJEb6qKYFGBQM0HPz9IZYPkFD7FlZyifcWNrFEjlM4LJiyAQcunx30b5EMcz8oT7YjYIo5Bb2DOsnIt6uAdkOmUPUmY%2FzM3PmuL6ZYePw7XBzfBYcfiNqZPHWFO6x0%2FmP5sl5TFTspcBFiC1tU5q9L40pvlUpeAHA0lByHoziRM9b9aIUnBzO8cEmGGLYvEv9AlDEIduUMLKL470GOqYBeuzvU%2B1K1xvzamOk1TaDeko%2BJlQ8xUgcguCKvnE%2BpYSn9MQz0SIXrm4hUrSnIO%2FjFoTZ4esBSlXTCkXH%2F6%2BRHttOAoEAfv1XQWO8%2Bsv2qVS97SrODEBLVhY1tfEFQcw%2BZ93GUo5LYHe1U2PubGkf9wTLJ5AZCq5Vr1%2FKLwVlulVfHEhtz4E3fzOL1TPO7tIclZor0kZmzjAwtkky7VHrQVXehNV3Gw%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=0b31bf32427b3c3f66e6cc5ea157e31f98d5730504e0d17280d2bc5e28c336a3",
    "social_links": [
        "http://twitter.com/helixnano",
        "https://www.crunchbase.com/organization/helixnano"
    ],
    "logo_path": "data/logos\\Helix_Nanotechnologies_logo.png"
}